Orfali, R.; AlFaiz, A.; Alanazi, M.; Alabdulsalam, R.; Alharbi, M.; Alromaih, Y.; Dallak, I.; Alrahal, M.; Alwatban, A.; Saud, R.
TRPV4 Channel Modulators as Potential Drug Candidates for Cystic Fibrosis. Int. J. Mol. Sci. 2024, 25, 10551.
https://doi.org/10.3390/ijms251910551
AMA Style
Orfali R, AlFaiz A, Alanazi M, Alabdulsalam R, Alharbi M, Alromaih Y, Dallak I, Alrahal M, Alwatban A, Saud R.
TRPV4 Channel Modulators as Potential Drug Candidates for Cystic Fibrosis. International Journal of Molecular Sciences. 2024; 25(19):10551.
https://doi.org/10.3390/ijms251910551
Chicago/Turabian Style
Orfali, Razan, Ali AlFaiz, Madhawi Alanazi, Rahaf Alabdulsalam, Meaad Alharbi, Yara Alromaih, Ismail Dallak, Marah Alrahal, Abdulaziz Alwatban, and Reem Saud.
2024. "TRPV4 Channel Modulators as Potential Drug Candidates for Cystic Fibrosis" International Journal of Molecular Sciences 25, no. 19: 10551.
https://doi.org/10.3390/ijms251910551
APA Style
Orfali, R., AlFaiz, A., Alanazi, M., Alabdulsalam, R., Alharbi, M., Alromaih, Y., Dallak, I., Alrahal, M., Alwatban, A., & Saud, R.
(2024). TRPV4 Channel Modulators as Potential Drug Candidates for Cystic Fibrosis. International Journal of Molecular Sciences, 25(19), 10551.
https://doi.org/10.3390/ijms251910551